This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignees: Helmholtz-Zentrum Fur Infektionsforschung Gmbh, Medizinische Hochschule Hannover, Gottfried Wilhelm Leibniz Universitat Hannover. Active years: 2012-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 28 
2 out of 88 
1 out of 13 Years Active: 2012-2016
Title: Nisar Malek: Innovator in Macrocycle Research
Introduction
Nisar Malek is a prominent inventor based in Hannover, Germany. He has made significant contributions to the field of macrocycle research, particularly in the development of inhibitors for proteasomic degradation.
Latest Patents
Nisar Malek holds 2 patents. His latest patents include a method for producing intermediates for the production of novel macrocycles that are inhibitors of the proteasomic degradation of p27, such as argyrin and its derivatives. This invention focuses on the use of these macrocycles for treating various conditions, including immunotolerance induction, autoimmune diseases, bacterial infections, and proliferative diseases like cancer. Another patent involves the use of inhibitors of p27 degradation, specifically argyrin and its derivatives, for treating proliferative diseases, emphasizing the potential of Argyrin A in cancer treatment.
Career Highlights
Throughout his career, Nisar Malek has worked with esteemed institutions such as Medizinische Hochschule Hannover and Helmholtz-Zentrum für Infektionsforschung GmbH. His research has been pivotal in advancing the understanding of macrocycles and their applications in medicine.
Collaborations
Nisar has collaborated with notable colleagues, including Markus Kalesse and Ronald Frank, contributing to the advancement of research in his field.
Conclusion
Nisar Malek's innovative work in macrocycle research and his patents highlight his significant impact on the treatment of various diseases. His contributions continue to pave the way for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile